Endothelial dysfunction is related to aldosterone excess and raised blood pressure

Endocrine Journal

Volumn 56, Issue 4, 2009, Pages 553-559

  Tsuchiya, Kyoichiro ^a   Yoshimoto, Takanobu ^a   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Endothelial dysfunction; Flow mediated vasodilation; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; SPIRONOLACTONE;

ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ANKLE BRACHIAL INDEX; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERTENSION; MALE; PRIMARY HYPERALDOSTERONISM; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

AGED; ALDOSTERONE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; RENIN; VASODILATION;

EID: 68449090297     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-014     Document Type: Article

References (26)

1. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045-1050. (Pubitemid 38368386)
2. Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC (2001) Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 86: 1083-1090. (Pubitemid 32322986)
3. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193-202. (Pubitemid 38489081)
4. Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P, Pessina AC (1996) Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 27: 1039-1045. (Pubitemid 26140658)
5. Halimi JM, Mimran A (1995) Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 13: 1801-1802. (Pubitemid 26015820)
6. Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T (1995) Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The research committee of disorders of adrenal hormones in Japan. J Endocrinol Invest 18: 370-373.
7. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115: 1285-1295. (Pubitemid 46594773)
8. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan IS, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-1115.
9. Nishizaka MK, Zaman MA, Green SA, Renfroe KY, Calhoun DA (2004) Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation 109: 2857-2861. (Pubitemid 38780298)
10. Farquharson CA, Struthers AD (2002) Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci (Lond) 103: 425-431.
11. Tsuchiya K, Nakayama C, Iwashima F, Sakai H, Izumiyama H, Doi M, Hirata Y (2007) Advanced endothelial dysfunction in diabetic patients with multiple risk factors; importance of insulin resistance. J Atheroscler Thromb 14: 303-309.
12. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE (1990) abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27. (Pubitemid 20209468)
13. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA (1996) Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27: 567-574. (Pubitemid 26081917)
14. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. implications for the syndrome of insulin resistance. J Clin Invest 97: 2601-2610. (Pubitemid 26187348)
15. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ (1990) Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86: 228-234. (Pubitemid 20226996)
16. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, et al. (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26: 1235-1241.
17. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM (2007) Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study. Circulation 115: 2390-2397. (Pubitemid 46717961)
18. Rossi R, Nuzzo A, Origliani G, Modena MG (2008) Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 51: 997-1002. (Pubitemid 351318128)
19. Oliver JJ, Webb DJ (2003) Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23: 554-566.
20. Kinlay S, Creager MA, Fukumoto M, Hikita H, Fang Jc, Selwyn AP, Ganz P (2001) Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 38: 1049-1053. (Pubitemid 34252804)
21. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR (2002) Nitric oxide regulates local arterial distensibility in vivo. Circulation 105: 213-217. (Pubitemid 34084321)
22. Duffy SJ, Biegelsen ES, Eberhardt RT, Kahn DF, Kingwell BA, Vita JA (2005) Low-renin hypertension with relative aldosterone excess is associated with impaired no-mediated vasodilation. Hypertension 46: 707-713.
23. Nagata D, Takahashi M, Sawai K, Tagami T, Usui T, Shimatsu A, Hirata Y, Naruse M (2006) Molecular mechanism of the inhibitory effect of aldosterone on endothelial no synthase activity. Hypertension 48: 165-171. (Pubitemid 44297539)
24. Iwashima F, Yoshimoto T, Minami I, Sakurada M, Hirono Y, Hirata Y (2008) Aldosterone induces superoxide generation via rac1 activation in endothelial cells. Endocrinology 149: 1009-1014.
25. Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844. (Pubitemid 30943820)
26. Hirono Y, Yoshimoto T, Suzuki N, Sugiyama T, Sakurada M, Takai S, Kobayashi N, Shichiri M, Hirata Y (2007) Angiotensin ii receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system. Endocrinology 148: 1688-1696. (Pubitemid 46457130)